Abstract
IFN-α and skin-infiltrating activated T lymphocytes have important roles in the pathogenesis of psoriasis. T cells from psoriatic patients display an increased sensitivity to IFN-α, but the pathological mechanisms behind the hyperresponsiveness to IFN-α remained unknown. In this study, we show that psoriatic T cells display deficient expression of the suppressor of cytokine signaling (SOCS)3 in response to IFN-α and a low baseline expression of the SH2-domain-containing protein-tyrosine phosphatase (SHP)-1 when compared with skin T cells from nonpsoriatic donors. Moreover, IFN-α-stimulated psoriatic T cells show enhanced activation of JAKs (JAK1 and TYK2) and signal transducers and activators of transcription. Increased expression of SOCS3 proteins resulting from proteasomal blockade partially inhibits IFN-α response. Similarly, forced expression of SOCS3 and SHP-1 inhibits IFN-α signaling in psoriatic T cells. In conclusion, our data suggest that loss of regulatory control is involved in the aberrant hypersensitivity of psoriatic T cells to IFN-α. © 2010 The Society for Investigative Dermatology.
Cite
CITATION STYLE
Eriksen, K. W., Woetmann, A., Skov, L., Krejsgaard, T., Bovin, L. F., Hansen, M. L., … Ødum, N. (2010). Deficient SOCS3 and SHP-1 expression in psoriatic T cells. Journal of Investigative Dermatology, 130(6), 1590–1597. https://doi.org/10.1038/jid.2010.6
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.